Monday, June 15, 2026

Kim Jong Un emphasize ‘Young Patriot’… Reporting Chinese and Russian Leader’s New Year Speeches

Kim Jong Un praised young builders during his visit to the Sinuiju Greenhouse Complex, emphasizing their role in national prosperity.

North Korea Raises Drone Allegations as Seoul Denies Involvement and Launches Internal Review

National Security Advisor Wi Seong Rak addresses North Korea's drone allegations, emphasizing internal investigations and legal frameworks.

1969 Korean Air Hijacking: North Korean Operatives Take Flight to North Korea

The hijacking of Korean Air YS-11 in 1969 by North Korean operatives highlights tensions and impacts on inter-Korean relations.

Tag: solid tumors

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.